Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Sharda Cropchem IPO is 45. Their analysis recommends May Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 45 | May Subscribe |
[Dilip Davda] <p> </p> <p style="margin: 0in 0in 0pt; text-align: justify;"><span style="font-family: Calibri; font-size: medium;">On merchant banker’s front, both have positive bias on their past mandates. As such issue can be considered for medium to long term investment.</span><span style="font-family: Calibri; font-size: medium;"> </span></p> <p> </p> <p style="margin: 0in 0in 0pt; text-align: justify;"><strong><span style="font-family: Calibri; font-size: medium;">Remark: Apply</span></strong></p> Read detail review...
Sharda Cropchem IPO Reviews, analysis and views by popular members. Read Sharda Cropchem Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP